Cargando…

Prognostic implications of left ventricular mass-geometry in patients with no or nonobstructive coronary artery disease

BACKGROUND: Coronary computed tomography angiography (CCTA) is widely used as a first-line noninvasive modality that frequently exhibits no or nonobstructive coronary artery disease (CAD) in clinical practice, along with abnormal left ventricular (LV) geometry on echocardiography. However, the combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, You-Jung, Park, Jun-Bean, Park, Chan Soon, Hwang, Inchang, Yoon, Yeonyee E., Lee, Seung-Pyo, Kim, Hyung-Kwan, Kim, Yong-Jin, Cho, Goo-Yeong, Sohn, Dae-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051046/
https://www.ncbi.nlm.nih.gov/pubmed/33858344
http://dx.doi.org/10.1186/s12872-021-02005-6
_version_ 1783679687108591616
author Choi, You-Jung
Park, Jun-Bean
Park, Chan Soon
Hwang, Inchang
Yoon, Yeonyee E.
Lee, Seung-Pyo
Kim, Hyung-Kwan
Kim, Yong-Jin
Cho, Goo-Yeong
Sohn, Dae-Won
author_facet Choi, You-Jung
Park, Jun-Bean
Park, Chan Soon
Hwang, Inchang
Yoon, Yeonyee E.
Lee, Seung-Pyo
Kim, Hyung-Kwan
Kim, Yong-Jin
Cho, Goo-Yeong
Sohn, Dae-Won
author_sort Choi, You-Jung
collection PubMed
description BACKGROUND: Coronary computed tomography angiography (CCTA) is widely used as a first-line noninvasive modality that frequently exhibits no or nonobstructive coronary artery disease (CAD) in clinical practice, along with abnormal left ventricular (LV) geometry on echocardiography. However, the combined prognostic value of these findings has not been well elucidated. Therefore, we aimed to evaluate the prognostic implications of abnormal LV geometry in individuals with no or nonobstructive CAD. METHODS: A total of 5806 subjects with no CAD or nonobstructive CAD (luminal narrowing < 50%) on CCTA were included in the study. The major exclusion criteria were structural heart disease and a history of myocardial infarction or coronary revascularization. Abnormal LV geometry on echocardiography was defined as LV mass index > 95 g/m(2) in women and > 115 g/m(2) in men, and/or relative wall thickness > 0.42. The primary outcome was all-cause mortality. RESULTS: A total of 5803 subjects without significant obstructive CAD (age, 56.6 ± 8.87 years; men, 3884 [66.9%]). Of them, 4045 (69.7%) subjects had normal LV geometry and 1758 (30.3%) had abnormal LV geometry respectively. During a mean follow-up of 6.2 ± 1.48 years, 84 (1.44%) subjects died in the study population. Of these, 56 subjects were from the normal LV geometry group (1.24%) and 28 were from the abnormal LV geometry group (2.32%). Subjects with abnormal LV geometry had significantly worse survival rates (log-rank, p < 0.001). After adjustment for confounding factors, abnormal LV geometry was an independent predictor of all-cause mortality (adjusted hazard ratio, 1.64; 95% confidence interval, 1.04–2.58; p = 0.034). Moreover, abnormal LV geometry was significantly worse in survival when classified as those with no CAD (log-rank, p = 0.024) and nonobstructive CAD (Log-rank, p < 0.001). CONCLUSIONS: Abnormal LV geometry portends a worse prognosis in subjects with no or nonobstructive CAD. These findings suggest that LV geometry assessment can help improve the stratification of individuals with these CCTA findings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-021-02005-6.
format Online
Article
Text
id pubmed-8051046
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80510462021-04-19 Prognostic implications of left ventricular mass-geometry in patients with no or nonobstructive coronary artery disease Choi, You-Jung Park, Jun-Bean Park, Chan Soon Hwang, Inchang Yoon, Yeonyee E. Lee, Seung-Pyo Kim, Hyung-Kwan Kim, Yong-Jin Cho, Goo-Yeong Sohn, Dae-Won BMC Cardiovasc Disord Research BACKGROUND: Coronary computed tomography angiography (CCTA) is widely used as a first-line noninvasive modality that frequently exhibits no or nonobstructive coronary artery disease (CAD) in clinical practice, along with abnormal left ventricular (LV) geometry on echocardiography. However, the combined prognostic value of these findings has not been well elucidated. Therefore, we aimed to evaluate the prognostic implications of abnormal LV geometry in individuals with no or nonobstructive CAD. METHODS: A total of 5806 subjects with no CAD or nonobstructive CAD (luminal narrowing < 50%) on CCTA were included in the study. The major exclusion criteria were structural heart disease and a history of myocardial infarction or coronary revascularization. Abnormal LV geometry on echocardiography was defined as LV mass index > 95 g/m(2) in women and > 115 g/m(2) in men, and/or relative wall thickness > 0.42. The primary outcome was all-cause mortality. RESULTS: A total of 5803 subjects without significant obstructive CAD (age, 56.6 ± 8.87 years; men, 3884 [66.9%]). Of them, 4045 (69.7%) subjects had normal LV geometry and 1758 (30.3%) had abnormal LV geometry respectively. During a mean follow-up of 6.2 ± 1.48 years, 84 (1.44%) subjects died in the study population. Of these, 56 subjects were from the normal LV geometry group (1.24%) and 28 were from the abnormal LV geometry group (2.32%). Subjects with abnormal LV geometry had significantly worse survival rates (log-rank, p < 0.001). After adjustment for confounding factors, abnormal LV geometry was an independent predictor of all-cause mortality (adjusted hazard ratio, 1.64; 95% confidence interval, 1.04–2.58; p = 0.034). Moreover, abnormal LV geometry was significantly worse in survival when classified as those with no CAD (log-rank, p = 0.024) and nonobstructive CAD (Log-rank, p < 0.001). CONCLUSIONS: Abnormal LV geometry portends a worse prognosis in subjects with no or nonobstructive CAD. These findings suggest that LV geometry assessment can help improve the stratification of individuals with these CCTA findings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-021-02005-6. BioMed Central 2021-04-15 /pmc/articles/PMC8051046/ /pubmed/33858344 http://dx.doi.org/10.1186/s12872-021-02005-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Choi, You-Jung
Park, Jun-Bean
Park, Chan Soon
Hwang, Inchang
Yoon, Yeonyee E.
Lee, Seung-Pyo
Kim, Hyung-Kwan
Kim, Yong-Jin
Cho, Goo-Yeong
Sohn, Dae-Won
Prognostic implications of left ventricular mass-geometry in patients with no or nonobstructive coronary artery disease
title Prognostic implications of left ventricular mass-geometry in patients with no or nonobstructive coronary artery disease
title_full Prognostic implications of left ventricular mass-geometry in patients with no or nonobstructive coronary artery disease
title_fullStr Prognostic implications of left ventricular mass-geometry in patients with no or nonobstructive coronary artery disease
title_full_unstemmed Prognostic implications of left ventricular mass-geometry in patients with no or nonobstructive coronary artery disease
title_short Prognostic implications of left ventricular mass-geometry in patients with no or nonobstructive coronary artery disease
title_sort prognostic implications of left ventricular mass-geometry in patients with no or nonobstructive coronary artery disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051046/
https://www.ncbi.nlm.nih.gov/pubmed/33858344
http://dx.doi.org/10.1186/s12872-021-02005-6
work_keys_str_mv AT choiyoujung prognosticimplicationsofleftventricularmassgeometryinpatientswithnoornonobstructivecoronaryarterydisease
AT parkjunbean prognosticimplicationsofleftventricularmassgeometryinpatientswithnoornonobstructivecoronaryarterydisease
AT parkchansoon prognosticimplicationsofleftventricularmassgeometryinpatientswithnoornonobstructivecoronaryarterydisease
AT hwanginchang prognosticimplicationsofleftventricularmassgeometryinpatientswithnoornonobstructivecoronaryarterydisease
AT yoonyeonyeee prognosticimplicationsofleftventricularmassgeometryinpatientswithnoornonobstructivecoronaryarterydisease
AT leeseungpyo prognosticimplicationsofleftventricularmassgeometryinpatientswithnoornonobstructivecoronaryarterydisease
AT kimhyungkwan prognosticimplicationsofleftventricularmassgeometryinpatientswithnoornonobstructivecoronaryarterydisease
AT kimyongjin prognosticimplicationsofleftventricularmassgeometryinpatientswithnoornonobstructivecoronaryarterydisease
AT chogooyeong prognosticimplicationsofleftventricularmassgeometryinpatientswithnoornonobstructivecoronaryarterydisease
AT sohndaewon prognosticimplicationsofleftventricularmassgeometryinpatientswithnoornonobstructivecoronaryarterydisease